Dr Daniele Bergamaschi

Daniele Bergamaschi

Senior Lecturer

Blizard Institute/Centre for Cell Biology and Cutaneous Research
Queen Mary University of London, Faculty of Medicine & Dentistry

Research

Skin cancer, Autophagy, Epidermal homeostasis, Skin inflammageing, 3D in vitro models, Drug resistance

Interests

3D in vitro models provide physiologically relevant platforms for dissecting the molecular mechanisms that drive skin diseases. These systems recreate key aspects of the cutaneous microenvironment within controlled and reproducible settings, enabling detailed investigation of disease specific pathways, cell–cell and cell–matrix interactions, and tissue level responses. Their scalability, combined with compatibility with high throughput and high content analytical methodologies, further enhances their value for preclinical drug screening pipelines, supporting systematic evaluation of therapeutic efficacy, toxicity, and mechanism of action

Publications

solid heart iconPublications of specific relevance to Predictive in vitro Models

2026

P45 Impaired autophagy signalling in cutaneous squamous cell carcinoma: a novel therapeutic target
Fitzsimons A, Patel A, Thomson J, Wang J, Maffucci T, Harwood C, Bergamaschi D
British Journal of Dermatology, Oxford University Press (Oup) vol. 194 (1) 
06-01-2026
A-632 Investigating alterations in autophagy signalling during development and progression of cutaneous Squamous Cell Carcinoma
Fitzsimons A, Patel A, Wang J, Maffucci T, Harwood C, Bergamaschi D
Ejc Skin Cancer, Elsevier vol. 4 
01-01-2026

2025

A CD24+CD271+ melanoma cancer stem cell possesses hybrid characteristics of its single marker counterparts and promotes invasion and therapeutic resistance
Knowles O, Doldan P, Hillier-Richardson I, Lunetto S, Lunt S, Youssef G, Gammon L, Mackenzie IC et al.
Bmc Biology, Springer Nature vol. 23 (1) 
04-08-2025

2024

Biomechanical Activation of Keloid Fibroblasts Promotes Lysosomal Remodeling and Exocytosis
Ross R, Guo Y, Walker RN, Bergamaschi D, Shaw TJ, Connelly JT
Journal of Investigative Dermatology, Elsevier vol. 144 (12), 2730-2741.  
17-05-2024
Autophagy Modulation in Endothelial Hyperglycemia-Induced Wound-Healing Impairment
Bergamaschi D
Journal of Investigative Dermatology, Elsevier vol. 144 (5), 929-930.  
01-04-2024
Improving cancer stem cells killing in malignant melanoma
Bergamaschi D
British Journal of Dermatology, Oxford University Press (Oup) vol. 190 (5), 615-616.  
29-01-2024

2023

O09 Dynamic impact of chronic inflammation on epidermal autophagy pathway
Uddin N, Ostano P, Chiorino G, di Domizio J, Gilliet M, Philpott M, Hannen R, Bergamaschi D
British Journal of Dermatology, Oxford University Press (Oup) vol. 189 (1), e7-e8.  
07-07-2023
Similar local recurrence and survival in patients with T1 radial growth phase melanoma on head and neck treated with 5 or 10 mm margins: A retrospective study
Maurichi A, Barretta F, Patuzzo R, Miceli R, Gallino G, Mattavelli I, Leva A, Harwood C et al.
Journal of The European Academy of Dermatology and Venereology, Wiley vol. 37 (7), 1318-1326.  
27-03-2023

2022

347 Chronic Inflammation of Keratinocytes Leads to Autophagy Impairment in Psoriasis
Uddin N, Ostano P, Chiorino G, Philpott M, Hannen R, Bergamaschi D
Journal of Investigative Dermatology, Elsevier vol. 142 (12) 
01-12-2022
597 Altered mechano-sensing and autophagy in keloid dermal fibroblasts
Ross R, Bergamaschi D, Shaw TJ, Connelly J
Journal of Investigative Dermatology, Elsevier vol. 142 (12) 
01-12-2022
ESDR347 - Chronic Inflammation of Keratinocytes Leads to Autophagy Impairment in Psoriasis
Begum Uddin N, Ostano P, Chiorino G, Philpott M, Hannen R, Bergamaschi D
, Morressier 
27-09-2022
Retraction: iASPP is a novel autophagy inhibitor in keratinocytes
Chikh A, Sanzà P, Raimondi C, Akinduro O, Warnes G, Chiorino G, Byrne C, Harwood CA et al.
Journal of Cell Science, The Company of Biologists vol. 135 (14) 
15-07-2022
GJB5 association with BRAF mutation and survival in cutaneous malignant melanoma*
Scatolini M, Patel A, Grosso E, Mello‐Grand M, Ostano P, Coppo R, Vitiello M, Venesio T et al.
British Journal of Dermatology, Oxford University Press (Oup) vol. 186 (1), 117-128.  
01-01-2022
Chronic inflammation impairs autophagy in psoriasis
Uddin N, Ostano P, Chiorino G, Philpott M, Hannen R, Bergamaschi D
 
01-01-2022
Autophagy impairment and dysfunctional stress response in the pathophysiology of psoriasis
Uddin NB, Asher S, Mannella V, Varahan B, Purdie K, Leigh I, Philpott M, Hannen R et al.
 
01-01-2022

2021

Autophagy protects from photoageing in skin fibroblasts
Bergamaschi D
British Journal of Dermatology, Oxford University Press (Oup) vol. 186 (2), 211-212.  
15-11-2021
Growth and Viability of Cutaneous Squamous Cell Carcinoma Cell Lines Display Different Sensitivities to Isoform-Specific Phosphoinositide 3-Kinase Inhibitors
Mannella V, Boehm K, Celik S, Ali T, Mirza AN, Hasnaouy ME, Kaffa A, Lyu Y et al.
International Journal of Molecular Sciences, Mdpi vol. 22 (7) 
30-03-2021
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, Abdellatif M, Abdoli A, Abel S, Abeliovich H, Abildgaard MH et al.
Autophagy, Taylor & Francis vol. 17 (1), 1-382.  
02-01-2021

2020

Analysis of Sentinel Node Biopsy and Clinicopathologic Features as Prognostic Factors in Patients With Atypical Melanocytic Tumors.
Maurichi A, Miceli R, Patuzzo R, Barretta F, Gallino G, Mattavelli I, Barbieri C, Leva A et al.
Journal of The National Comprehensive Cancer Network, Harborside Press vol. 18 (10), 1327-1336.  
01-10-2020
Reply to E. Hindié.
Maurichi A, Miceli R, Eriksson H, Newton-Bishop J, Nsengimana J, Chan M, Hayes AJ, Heelan K et al.
Journal of Clinical Oncology, American Society of Clinical Oncology (Asco) vol. 38 (27), 3238-3240.  
23-07-2020
Targeting p63 Upregulation Abrogates Resistance to MAPK Inhibitors in Melanoma
Patel A, Garcia LF, Mannella V, Gammon L, Borg T-M, Maffucci T, Scatolini M, Chiorino G et al.
Cancer Research, American Association For Cancer Research (Aacr) vol. 80 (12), 2676-2688.  
15-06-2020
Factors Affecting Sentinel Node Metastasis in Thin (T1) Cutaneous Melanomas: Development and External Validation of a Predictive Nomogram.
Maurichi A, Miceli R, Eriksson H, Newton-Bishop J, Nsengimana J, Chan M, Hayes AJ, Heelan K et al.
J Clin Oncol vol. 38 (14), 1591-1601.  
13-03-2020

2019

The desmosomal cadherin desmoglein-3 acts as a keratinocyte anti-stress protein via suppression of p53
Rehman A, Cai Y, Hünefeld C, Jedličková H, Huang Y, Teck Teh M, Sharif Ahmad U, Uttagomol J et al.
Cell Death & Disease, Springer Nature vol. 10 (10) 
03-10-2019
GJB5 association with BRAF mutation and survival in cutaneous melanoma
Scatolini M, Grosso E, Mello-Grand M, Ostano P, Coppo R, Patel A, Vitiello M, Venesio T et al.
ESDR 2019 Bordeaux September 2019. 
01-09-2019
Simultaneous polychromatic flow cytometric detection of multiple forms of regulated cell death
Bergamaschi D, Vossenkamper A, Lee WYJ, Wang P, Bochukova E, Warnes G
Apoptosis, Springer Nature vol. 24 (5-6), 453-464.  
20-02-2019
Epigenetic Regulation of iASPP-p63 Feedback Loop in Cutaneous Squamous Cell Carcinoma
Robinson DJ, Patel A, Purdie KJ, Wang J, Rizvi H, Hufbauer M, Ostano P, Akgül B et al.
Journal of Investigative Dermatology, Elsevier vol. 139 (8), 1658-1671.e8.  
30-01-2019
Targeting selective phosphoinositide-3-kinase isoforms as a novel strategy in cutaneous squamous cell carcinoma
Mannella V, Bergamaschi D, Harwood C, Maffucci T
 
01-01-2019
Dissecting the integrity of epidermal autophagy in human eczema samples
Jiang Q, Alabi I-KA, Bergamaschi D
 
01-01-2019

2018

76P Targeting p63 upregulation may prevent the development of MAPK inhibitor resistance in melanoma
Borg T-M, Patel A, Bergamaschi D, Harwood C
 
01-09-2018
1347 Desmoglein-3 acts as an anti-stress protein via suppression of p53
Rehman A, Cai Y, Jedliková H, Harwood C, Bergamaschi D, Wan H
Journal of Investigative Dermatology, Elsevier vol. 138 (5) 
01-05-2018
Desmoglein-3 acts as an anti-stress protein via suppression of p53
Rehman A, Cai Y, Jedlikova H, Harwood C, Bergamaschi D, Wan H
 
01-01-2018
Novel role of desmoglein-3 acting as a negative regulator of p53
Rehman A, Cai Y, Jedlickova H, Harwood C, Bergamaschi D, Wan H
 
01-01-2018
Targeting p63 upregulation may prevent development of mitogen-activated protein kinase inhibitor resistance in melanoma
Patel AV, Borg T-M, Rodolfo M, Posch C, Harwood C, Bergamaschi D
 
01-01-2018
Identification of a novel cancer stem cell subpopulation in melanoma pathological specimens
Knowles O, Doldan P, Hillier-Richardson I, Lunt S, Gammon L, Youssef G, Harwood C, Mackenzie I et al.
 
01-01-2018

2017

Uncovering mechanisms of nuclear degradation in keratinocytes: A paradigm for nuclear degradation in other tissues.
Rogerson C, Bergamaschi D, O'Shaughnessy RFL
Nucleus, 1-9.  
05-12-2017
p63 signalling in BRAF inhibitor resistant melanoma
Patel A, Harwood CA, Bergamaschi D
European Society of Investigative Dermatology 2017. 
01-10-2017

2016

Epidermal autophagy and nucleophagy
Akinduro O, Harwood CA, O'Shaughnessy R, Bergamaschi D
European Society of Investigative Dermatology. 
14-09-2016
Constitutive Autophagy and Nucleophagy during Epidermal Differentiation
Akinduro O, Sully K, Patel A, Robinson DJ, Chikh A, McPhail G, Braun KM, Philpott MP et al.
Journal of Investigative Dermatology vol. 136 (7), 1460-1470.  
01-07-2016
P63 contributes to acquired BRAF inhibitor resistance in melanoma
Patel A, Harwood C, Bergamaschi D
British Society of Investigative Dermatology 2016. 
01-05-2016
Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression
Chikh A, Ferro R, Abbott JJ, Piñeiro R, Buus R, Iezzi M, Ricci F, Bergamaschi D et al.
Oncotarget, Impact Journals vol. 7 (14), 18325-18345.  
26-02-2016
Erratum
Autophagy, Taylor & Francis vol. 12 (2), 443-443.  
01-02-2016
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM et al.
Autophagy, Taylor & Francis vol. 12 (1), 1-222.  
02-01-2016

2015

Dissecting the role of iASPP, a novel regulator of epidermal homeostasis, in keratinocyte skin carcinogenesis
Robinson D, Harwood C, Bergamaschi D
 
01-01-2015

2014

Prediction of survival in patients with thin melanoma: results from a multi-institution study.
Maurichi A, Miceli R, Camerini T, Mariani L, Patuzzo R, Ruggeri R, Gallino G, Tolomio E et al.
J Clin Oncol vol. 32 (23), 2479-2485.  
10-08-2014
IASPP is a novel autophagy mudulator in keratinocytes
Chikh A, Sanza P, Raimondi C, Akinduro O, Warnes G, Chiorino G, Byrne C, Harwood CA et al.
J Cell Science, Company of Biologists vol. 127 (14), 3079-3093.  
28-04-2014
Is Mcl-1L the new anti-apoptotic effector of B-RAFV(600E) in melanoma?
Bergamaschi D
Exp Dermatol vol. 23 (2) 
01-02-2014
BRAF inhibitors reactivate tumor suppressive and oncogenic p53 activities in melanoma
Botti E, Fausti F, Spallone G, Levesque M, Bergamaschi D, Guerrini L, Dummer R, Costanzo A
 
01-01-2014

2013

p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis.
Matin RN, Chikh A, Chong SLP, Mesher D, Graf M, Sanza' P, Senatore V, Scatolini M et al.
J Exp Med vol. 210 (3), 581-603.  
11-03-2013
ASPP1 and ASPP2 bind active RAS, potentiate RAS signalling and enhance p53 activity in cancer cells.
BERGAMASCHI D, Wang, Y, Godin-Heymann N, Dan Wang X, Llanos S, Lu X
Cell Death and Differentiation, Nature Publishing Group vol. 20 (4), 525-534.  
01-01-2013
IASPP is a novel autophagy inhibitor in keratinocytes
Chikh A, Harwood C, Bergamaschi D
 
01-01-2013
Constitutive autophagy as a terminal differentiation mechanism
Akinduro O, Sully K, Chikh A, O'shaughnessy RF, Bergamaschi D, Harwood CA, Philpott MP, Byrne C
 
01-01-2013
The receptor tyrosine kinase, Axl, as a therapeutic target in malignant melanoma
Szentpetery Z, Lovat PE, Bergamaschi D, O'Toole EA
 
01-01-2013

2012

NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificity.
Wang H, Lee S, Nigro CL, Lattanzio L, Merlano M, Monteverde M, Matin R, Purdie K et al.
Br J Cancer vol. 106 (8), 1446-1452.  
10-04-2012
p63, an alternative p53 repressor in melanoma which confers chemoresistance and a poor prognosis
Matin RN, Chikh A, Law S, Harwood CA, Bergamaschi D
 
01-01-2012
Autophagy in epidermis
Akinduro O, Sully K, O'Shaughnessy RFL, Harwood CA, Bergamaschi D, Byrne C
 
01-01-2012
A Novel Mechanism of Keratinocyte Terminal Differentiation - Autophagy?
Akinduro O, Sully K, O'Shaughnessy R, Harwood CA, Bergamaschi D, Byrne C
 
01-01-2012
p63, a p53 repressor in melanoma which confers chemoresistance and a poor prognosis
Matin RN, Chikh A, Chong SLP, Harwood C, Bergamaschi D
 
01-01-2012

2011

iASPP/p63 autoregulatory feedback loop is required for the homeostasis of stratified epithelia.
Chikh A, Matin RNH, Senatore V, Hufbauer M, Lavery D, Raimondi C, Ostano P, Mello-Grand M et al.
Embo J vol. 30 (20), 4261-4273.  
06-09-2011
iASPP mediates regulation of autophagy in keratinocytes
Chikh A, Bergamaschi D
 
11-04-2011
iASPP/p63 auto-regulatory feedback loop is essential for epithelial integrity and autophagy
Chikh A, Bergamaschi D
 
01-04-2011
Inhibitory Member of the Apoptosis-stimulating Proteins of the p53 Family (iASPP) Interacts with Protein Phosphatase 1 via a Noncanonical Binding Motif.
Llanos S, Royer C, Lu M, Bergamaschi D, Lee WH, Lu X
J Biol Chem. vol. 286 (50), 43039-43044.  
01-01-2011

2010

iASPP: a novel and essential key regulator of skin homeostasis
Chikh A, Matin R, Harwood CA, Bergamaschi D
 
01-04-2010
p63 is implicated in apoptotic dysregulation in melanoma
Matin RN, Chikh A, Warnes G, Proby CM, Leigh IM, Harwood CA, Bergamaschi D
 
01-04-2010

2009

A novel Role of iASPP, a key regulator in skin development
Chikh A, Bergamaschi D
 
01-09-2009

2008

P63 is implicated in apoptotic deregulation in melanoma
Matin R, Hajji N, Chikh A, Harwood CA, Bergamaschi D
 
01-04-2008

2007

Models for Skin Cancer
Philpott MP, Bergamaschi D, Storey A
In The Cancer Handbook, Wiley 
15-10-2007
A p53-derived apoptotic peptide derepresses p73 to cause tumor regression in vivo
Bell HS, Dufes C, O'Prey J, Crighton D, Bergamaschi D, Lu X, Schatzlein AG, Vousden KH et al.
J Clin Invest vol. 117 (4), 1008-1018.  
01-04-2007
Role of HPV E6 proteins in preventing UVB-induced release of pro-apoptotic factors from the mitochondria
Leverrier S, Bergamaschi D, Ghali L, Ola A, Warnes G, Akgul B, Blight K, Garcia-Escudero R et al.
Apoptosis vol. 12 (3), 549-560.  
01-03-2007
A new inhibitor of apoptosis from vaccinia virus and eukaryotes.
Gubser C, Bergamaschi D, Hollinshead M, Lu X, van Kuppeveld FJM, Smith GL
Plos Pathog vol. 3 (2) 
01-02-2007

2006

iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72 polymorphic p53
Bergamaschi D, Samuels Y, Sullivan A, Zvelebil M, Breyssens H, Bisso A, Del Sal G, Syed N et al.
Nat Genet vol. 38 (10), 1133-1141.  
01-10-2006

2005

Mdm2 and mdmX prevent ASPP1 and ASPP2 from stimulating p53 without targeting p53 for degradation
Bergamaschi D, Samuels Y, Zhong S, Lu X
Oncogene vol. 24 (23), 3836-3841.  
26-05-2005
Posttranslational modifications of p27kip1 determine its binding specificity to different cyclins and cyclin-dependent kinases in vivo
Zhang WQ, Bergamaschi D, Jin BQ, Lu X
Blood vol. 105 (9), 3691-3698.  
01-05-2005

2004

The N-terminus of a novel isoform of human iASPP is required for its cytoplasmic localization.
Slee EA, Gillotin S, Bergamaschi D, Royer C, Llanos S, Ali S, Jin B, Trigiante G et al.
Oncogene vol. 23 (56), 9007-9016.  
02-12-2004
Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo.
Sullivan A, Syed N, Gasco M, Bergamaschi D, Trigiante G, Attard M, Hiller L, Farrell PJ et al.
Oncogene vol. 23 (19), 3328-3337.  
22-04-2004
ASPP1 and ASPP2: common activators of p53 family members.
Bergamaschi D, Samuels Y, Jin B, Duraisingham S, Crook T, Lu X
Mol Cell Biol vol. 24 (3), 1341-1350.  
01-02-2004

2003

p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis.
Bergamaschi D, Gasco M, Hiller L, Sullivan A, Syed N, Trigiante G, Yulug I, Merlano M et al.
Cancer Cell vol. 3 (4), 387-402.  
01-04-2003
iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human.
Bergamaschi D, Samuels Y, O'Neil NJ, Trigiante G, Crook T, Hsieh J-K, O'Connor DJ, Zhong S et al.
Nat Genet vol. 33 (2), 162-167.  
01-02-2003

2001

ASPP proteins specifically stimulate the apoptotic function of p53.
Samuels-Lev Y, O'Connor DJ, Bergamaschi D, Trigiante G, Hsieh JK, Zhong S, Campargue I, Naumovski L et al.
Mol Cell vol. 8 (4), 781-794.  
01-10-2001
Ecteinascidin-743 (ET-743), a natural marine compound, with a unique mechanism of action.
Erba E, Bergamaschi D, Bassano L, Damia G, Ronzoni S, Faircloth GT, D'Incalci M
Eur J Cancer vol. 37 (1), 97-105.  
01-01-2001

2000

Isolation and characterization of an IGROV-1 human ovarian cancer cell line made resistant to Ecteinascidin-743 (ET-743)
Erba E, Bergamaschi D, Bassano L, Ronzoni S, Di Liberti G, Muradore I, Vignati S, Faircloth G et al.
British Journal of Cancer, Springer Nature vol. 82 (10), 1732-1739.  
21-04-2000

1999

Mode of action of thiocoraline, a natural marine compound with anti-tumour activity
Erba E, Bergamaschi D, Ronzoni S, Faretta M, Taverna S, Bonfanti M, Catapano CV, Faircloth G et al.
British Journal of Cancer, Springer Nature vol. 80 (7), 971-980.  
07-05-1999
The novel synthetic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) causes apoptosis in acute promyelocytic leukemia cells through rapid activation of caspases.
Mologni L, Ponzanelli I, Bresciani F, Sardiello G, Bergamaschi D, Giannı́ M, Reichert U, Rambaldi A et al.
Blood, American Society of Hematology vol. 93 (3), 1045-1061.  
01-02-1999
The Novel Synthetic Retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene Carboxylic Acid (CD437) Causes Apoptosis in Acute Promyelocytic Leukemia Cells Through Rapid Activation of Caspases
Mologni L, Ponzanelli I, Bresciani F, Sardiello G, Bergamaschi D, Giannı́ M, Reichert U, Rambaldi A et al.
Blood, American Society of Hematology vol. 93 (3), 1045-1061.  
01-02-1999

1998

Cell cycle perturbations and apoptosis induced by isohomohalichondrin B (IHB), a natural marine compound
Bergamaschi D, Ronzoni S, Taverna S, Faretta M, Feudis PD, Faircloth G, Jimeno J, Erba E et al.
British Journal of Cancer, Springer Nature vol. 79 (2), 267-277.  
18-12-1998
In vitro schedule-dependency of myelotoxicity and cytotoxicity of Ecteinascidin 743 (ET-743)
Ghielmini M, Colli E, Erba E, Bergamaschi D, Pampallona S, Jimeno J, Faircloth G, Sessa C
Annals of Oncology, Elsevier vol. 9 (9), 989-993.  
01-09-1998
Characterization of cyclin B1 expression in human cancer cell lines by a new three‐parameter BrdUrd/Cyclin B1/DNA analysis
Faretta M, Bergamaschi D, Taverna S, Ronzoni S, Pantarotto M, Mascellani E, Cappella P, Ubezio P et al.
Cytometry, Wiley vol. 31 (1), 53-59.  
01-01-1998
Thiocoraline, a novel DNA polymerase inhibitor with a higher cytotoxic potency against cancer cells with mutated or inactivated p53
Erba E, Bergamaschi D, Ronzoni S, Faretta M, Bassano L, Vikhanskaya F, Jimeno J, Faircloth G et al.
Annals of Oncology vol. 9, 141-141.  
01-01-1998
Mode of action of Ecteinascidin 743, a natural marine compound with antitumoral activity
Erba E, Bergamaschi D, Ronzoni S, Faretta M, Bassano L, Cappella P, Valoti G, Giavazzi R et al.
Annals of Oncology vol. 9, 139-139.  
01-01-1998

1997

Treatment with inhibitors of polyamine biosynthesis, which selectively lower intracellular spermine, does not affect the activity of alkylating agents but antagonizes the cytotoxicity of DNA topoisomerase II inhibitors
Desiderio M, Bergamaschi D, Mascellani E, De Feudis P, Erba E, D'Incalci M
British Journal of Cancer, Springer Nature vol. 75 (7), 1028-1034.  
01-04-1997
Flow cytometric analysis of cell cycle phase perturbations induced by Thiocoraline, a new marine-derived anticancer compound.
Bergamaschi D, Faretta M, Ronzoni S, Taverna S, De Feudis P, Bonfanti M, Guidi G, Faircloth M et al.
 
01-01-1997
Differences in cyclin B1 expression in cells blocked in the G2M phase after treatment with anticancer agent. New three-parametric flow cytometric analysis.
Faretta M, Bergamaschi D, Ronzoni S, D'Incalci M, Erba E
 
01-01-1997

The Pemphigus Vulgaris antigen desmoglein-3 suppresses p53 function via the YAP-Hippo pathway
Rehman A, Cai Y, Hünefeld C, Jedličková H, Huang Y, Teh MT, Uttagomol J, Kang A et al.
In Biorxiv 
A CD24+CD271+ Melanoma Cancer Stem Cell Possesses Hybrid Characteristics of its Single Marker Counterparts and Promotes Invasion and Therapeutic Resistance
Knowles O, Doldan P, Hillier-Richardson I, Lunt S, Youssef G, Gammon L, Mackenzie IC, Philpott MP et al.
In Biorxiv 
A biomechanical switch promotes lysosomal remodelling and exocytosis in keloid fibroblasts
Ross R, Guo Y, Walker RN, Bergamaschi D, Shaw TJ, Connelly JT
In Biorxiv